Literature DB >> 7393988

Effects of 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy carboxyl methoxy coumarin (AD6) on aggregation, arachidonic acid metabolism and thromboxane B2 formation in human platelets.

C Galli, E Agradi, A Petroni, A Socini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7393988     DOI： 10.1016/s0031-6989(80)80089-0

Source DB:  PubMed          Journal:  Pharmacol Res Commun        ISSN： 0031-6989


× No keyword cloud information.
  8 in total

1.  Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.

Authors:  S Cuzzocrea; E Mazzon; C Bevilaqua; G Costantino; D Britti; G Mazzullo; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  The coumarin derivative AD6 inhibits the release of arachidonic acid by interfering with phospholipase A2 activity in human platelets stimulated with thrombin.

Authors:  S Porcellati; V Costantini; M Prosdocimi; M Stasi; R Pistolesi; G G Nenci; G Goracci
Journal:  Agents Actions       Date:  1990-03

3.  Cloricromene, a coumarine derivative, reduced the development of periodontitis in rats.

Authors:  Carmelo Muià; Emanuela Mazzon; Daniele Zito; Daniele Maiere; Domenico Britti; Concetta Crisafulli; Giacomo Oteri; Giancarlo Cordasco; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-28       Impact factor: 3.000

4.  Action of AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmet hox y coumarin) on human platelets in vitro.

Authors:  M Prosdocimi; A Zatta; A Gorio; A Zanetti; E Dejana
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-03       Impact factor: 3.000

5.  In vitro inhibition of human polymorphonuclear cell function by cloricromene.

Authors:  F Bertocchi; F Breviario; P Proserpio; J M Wang; P Ghezzi; R A Travagli; M Prosdocimi; E Dejana
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

6.  Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene.

Authors:  Rosario Pignatello; Nadia Ricupero; Claudio Bucolo; Francesco Maugeri; Adriana Maltese; Giovanni Puglisi
Journal:  AAPS PharmSciTech       Date:  2006-03-24       Impact factor: 3.246

7.  Dissociation of the anti-ischaemic effects of cloricromene from its anti-platelet activity.

Authors:  P S Lidbury; R Cirillo; J R Vane
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

8.  Multiple actions of the coumarine derivative cloricromene and its protective effects on ischemic brain injury.

Authors:  G Calapai; F Squadrito; A Rizzo; M C Marciano; G M Campo; A P Caputi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-02       Impact factor: 3.000
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.